Add
STEM to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| STEM > SEC Filings for STEM > Form 8-K on 13-Feb-2013 | All Recent SEC Filings |
13-Feb-2013
Other Events, Financial Statements and Exhibits
On February 12, 2013, StemCells, Inc. (the "Company") issued a press release with an update on the first patient cohort in the Company's Phase I/II clinical study in chronic spinal cord injury. The patients in the first cohort, consisting of three AIS A patients, have completed the study and twelve-month data from this cohort continued to demonstrate a favorable safety profile for the product and procedure and showed that the gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable. One of the patients in the cohort has converted from a complete injury assessment (AIS A) to an incomplete injury assessment (AIS B).
A copy of this press release is attached hereto as Exhibit 99.1.
(d) Exhibits
Exhibit 99.1 Press Release, dated February 12, 2013, announcing twelve-month data on the first patient cohort in the Company's clinical study of HuCNS-SC cells in spinal cord injury.
|
|